Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,062 total articles
Zscaler (ZS) is trading near $140 after a sector-wide repricing. The company sits at the intersection of zero-trust security and a rising need to protect AI infrastructure. With a market cap of roughly $22.4B, solid free cash flow ($947M trailing), improving technical breadth and elevated short interest, this is an actionable long trade to buy the …
Palantir is undergoing a re-rating as its Foundry AI adoption accelerates in commercial markets while the government business remains a steady revenue anchor. Recent weakness creates a tactical entry for disciplined buyers. This trade idea lays out an actionable plan, valuation context, catalysts, and the risks that would change our view.
Globant (GLOB) trades like a company in distress at $45.61 while its fundamentals and product roadmap suggest a reasonable rebound. Sub-$2B market cap, a P/B near 1.0 and recent technical signals support a swing trade with asymmetric reward-to-risk. Entry $45.61, stop $41.00, target $60.00 - mid-term (45 trading days) setup with targeted catalysts …
Sysco's $29.1B purchase of Jetro Restaurant Depot materially reshapes its scale and margin profile. The combination pushes pro forma revenue toward ~$100B and management projects ~45% EBITDA uplift and $250M of annual cost synergies. The market sold off on deal risk and leverage worries; that creates a tactical long opportunity at today's ~$75.19 q…
Eli Lilly is priced for high growth but the stock still offers an asymmetric risk/reward: new oral GLP-1 approval and a dominant pipeline combined with strong cash generation and recent strategic M&A give buyers a clear entry for a long-term position. This trade idea lays out the rationale, exact entry/stop/target, catalysts, and the scenarios that…
Apple's recent pullback on reports of engineering challenges for a foldable iPhone looks like an overreaction. Strong cash flow, conservative AI strategy, and a huge installed base mean a September launch expectation can be missed without derailing the business. This trade idea lays out an entry at $258.00, a stop at $245.00, and a target of $285.0…
Mesoblast’s FDA clearance to proceed directly to a registrational trial of Ryoncil (remestemcel-L-rknd) in Duchenne muscular dystrophy (DMD) is a material derisking event for a company already showing commercial traction with its launched product. With Q1 net sales of $30.3M and H1 FY2026 product revenue of $48.7M producing an unusually high gross …
Dow rallied hard in March as petrochemical dislocations lifted U.S. players. After a rapid run and profit-taking, shares are digesting gains around $37.8 with valuation and dividend yield that support a tactical long. This note lays out an actionable swing trade: entry, stop, targets, catalysts and the scenarios that would make us change course.
Microsoft is the safest, biggest way to play the AI buildout. Strong free cash flow, high ROE, ongoing enterprise AI rollouts, and recent partnership wins underpin a trade that targets a re-rating as Azure monetizes agentic AI. Entry $377.00, stop $355.00, target $430.00 — position trade (45 trading days).
Dell is a direct beneficiary of rising AI and data-center spend and sits on a record server backlog. Recent market dislocations tied to a competitor create a window for share gains and a meaningful multiple re-rate. This trade targets a measured long bias over the next 180 trading days, with a clear entry, stop and target defined.
Zscaler has been punished with the broader software de-rating, but its cloud-native zero-trust stack and healthy cash generation make it a tactical long. Trade plan: enter at $141.00, stop $124.00, target $225.00 over a 180-trading-day horizon.
Energy Transfer (ET) trades near $18.91 with a 6.9% yield, a ~ $65B market cap, and a fee-heavy business mix that limits downside while offering upside from export and volume tailwinds. Valuation (P/E ~15.8, EV/EBITDA ~8.9) looks reasonable versus historical midstream ranges, supporting a tactical long with clear entry, stop and target levels.
B&G Foods (BGS) is trading like a distressed name yet still generates meaningful free cash flow and a double-digit headline yield. This trade idea is a tactical long designed to capture a rebound into a more reasonable valuation while respecting the company’s leverage and operational risks.
Roblox ($RBLX) has pulled back more than half from its 2025 highs and now trades near its 52-week low. The platform still generates meaningful free cash flow and draws conviction from large institutional buyers, but valuation and safety/legal headwinds keep risk elevated. This trade sets a clear entry at $57.57, a stop at $50.28, and a target of $9…
Astrana Health (ASTH) runs a delegated-risk, physician-centric population health platform that has delivered strong top-line growth and free cash flow. Shares trade near $28 with an EV/sales of ~0.68 and a free cash flow of $104.5M — attractive for a revenue-growing, risk-bearing operator. We lay out a mid-term (45 trading days) long trade with def…
Granite Construction has rebuilt margins, locked in materials integration benefits and sits squarely in the path of renewed public infrastructure spending. Technical momentum, improving fundamentals and manageable leverage support a mid-term long trade with a clear risk/reward.
Par Pacific has turned into a compact, high-return refining-and-logistics play: robust free cash flow, sub-1x EV/sales, and double-digit ROE. With refining crack spreads elevated and operational throughput strong, the stock looks actionable from current levels. I outline an entry, stop, and target for a long trade and the catalysts and risks that m…
Aehr Test Systems (AEHR) is surfacing as a niche but critical provider of wafer-level test and burn-in systems for AI data-center components. Recent orders for silicon photonics and AI processor customers have re-rated the stock. I recommend a tactical long swing with a $62 entry, $85 target and $48 stop, horizon ~45 trading days, betting on follow…
Lucid (LCID) is trading near its 52-week low after headline-driven selling and heavy short interest. Production and supplier snags have weighed on margins, but the market already prices in poor near-term unit economics. With a market cap of roughly $2.95B, heavy short positioning and improving technicals, this is a tactical long trade for traders w…
Oracle has quietly built an AI infrastructure business that combines software, purpose-built hardware, and deep enterprise relationships. While markets focus on hyperscalers and chip makers, Oracle's OCI + Exadata stack offers a lower-cost, easier-to-deploy route for enterprise GenAI. This trade idea buys the gap between perception and reality with…
Red Cat recently closed strategic M&A, landed institutional orders and signed cross-border partnerships that materially improve its product mix and addressable market. The balance sheet is clean and revenue is accelerating, yet the stock still shows momentum slack and macro-driven dips. This trade idea lays out a mid-term long with defined entry, s…
AutoZone's business combines high margins, strong cash generation, and a resilient mix of DIY and commercial customers. Near-term uncertainty has pressured sentiment and presented a defined risk-reward entry. We upgrade to Buy and lay out a specific trade plan with clear entry, target, and stop-loss levels.
AbbVie combines a 3.2% yield, industry-leading free cash flow and a growing immunology franchise that replaced Humira. The stock is digesting gains and trading near technical support; a disciplined long trade with tight risk control offers asymmetric reward if Skyrizi/Rinvoq execution and margin recovery persist.
Wingstop's share price has retraced aggressively from its 2025 highs after same-store sales went negative. At ~$174.88 the market has priced in a prolonged traffic problem; it has not fully priced in a plausible recovery and continued asset-light expansion. This trade idea lays out an entry at $174.88, a $220 target, and a $150 stop for a mid-term …
Armanino Foods has the product portfolio and recent top-line momentum to justify a tactical long. The valuation is modest in absolute terms - market cap ~$331M and P/E ~17 - but liquidity, OTC listing and execution risk keep this from being a buy-and-hold. Enter at $10.40 with a $12.25 target and $9.20 stop for a mid-term (45 trading days) swing th…
